Skip to main content

Eben Lichtman

Eben Lichtman, MD, is a UNC Lineberger Comprehensive Cancer Center member who focuses his research on the development of chimeric antigen receptor T-cell therapies for patients with acute myeloid leukemia and multiple myeloma. 

MD
Assistant Professor, Hematology
School of Medicine
UNC-Chapel Hill
Immunology

Area of Interest

Eben Lichtman, MD, focuses his research on the development of chimeric antigen receptor T-cell therapies for patients with acute myeloid leukemia and multiple myeloma.

Awards and Honors

  • American Society for Clinical Oncology (ASCO) Young Investigator Award, 2018
  • First place poster award, translational research category, UNC Lineberger Annual Retreat, 2017
  • Outstanding Fellow Award, North Carolina Oncology Association, 2017
  • Selected to participate in American Association for Cancer Research (AACR)/ASCO Molecular Biology in Clinical Oncology Workshop, Snowmass, CO, 2017
  • Selected for Immunotherapy T32 Training Grant, UNC-Chapel Hill, 2017
  • Selected to participate in AACR/ASCO Methods in Clinical Cancer Research Workshop, Vail, CO, 2016

Find publications on PubMed

Eben Lichtman